A detailed history of Charter Oak Capital Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Charter Oak Capital Management, LLC holds 3,390 shares of ABT stock, worth $385,239. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,390
Previous 3,546 4.4%
Holding current value
$385,239
Previous $403,000 12.66%
% of portfolio
0.04%
Previous 0.04%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

SELL
$100.73 - $112.44 $15,713 - $17,540
-156 Reduced 4.4%
3,390 $352,000
Q1 2024

Apr 23, 2024

BUY
$109.52 - $120.96 $5,804 - $6,410
53 Added 1.52%
3,546 $403,000
Q4 2023

Jan 26, 2024

SELL
$90.19 - $110.4 $450 - $552
-5 Reduced 0.14%
3,493 $384,000
Q3 2023

Oct 04, 2023

SELL
$95.53 - $114.62 $7,546 - $9,054
-79 Reduced 2.21%
3,498 $338,000
Q2 2023

Jul 20, 2023

BUY
$100.78 - $112.29 $403 - $449
4 Added 0.11%
3,577 $389,000
Q1 2023

Apr 19, 2023

BUY
$96.86 - $114.01 $8,426 - $9,918
87 Added 2.5%
3,573 $361,000
Q4 2022

Jan 20, 2023

BUY
$95.06 - $111.52 $285 - $334
3 Added 0.09%
3,486 $0
Q3 2022

Dec 06, 2022

SELL
$96.76 - $112.03 $126,175 - $146,087
-1,304 Reduced 27.24%
3,483 $337,000
Q2 2022

Jul 21, 2022

SELL
$102.07 - $123.37 $8,369 - $10,116
-82 Reduced 1.68%
4,787 $520,000
Q1 2022

May 05, 2022

BUY
$114.02 - $139.04 $207,060 - $252,496
1,816 Added 59.48%
4,869 $576,000
Q4 2021

Feb 09, 2022

BUY
$115.53 - $141.46 $346 - $424
3 Added 0.1%
3,053 $430,000
Q3 2021

Nov 08, 2021

BUY
$116.66 - $129.06 $2,333 - $2,581
20 Added 0.66%
3,050 $360,000
Q2 2021

Jul 29, 2021

BUY
$105.79 - $124.53 $5,712 - $6,724
54 Added 1.81%
3,030 $351,000
Q1 2021

May 17, 2021

BUY
$108.84 - $128.23 $435 - $512
4 Added 0.13%
2,976 $357,000
Q4 2020

Feb 12, 2021

BUY
$105.0 - $114.42 $312,060 - $340,056
2,972 New
2,972 $325,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Charter Oak Capital Management, LLC Portfolio

Follow Charter Oak Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charter Oak Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Charter Oak Capital Management, LLC with notifications on news.